werner@aecom.UUCP (Craig Werner) (10/01/85)
From: AMN 9/13/85 p. 36 "Diabetics vision problem's aided." Suldinac, a non-steroidal anti-inflammatory drug (Aspirin, Tylenol, and Motrin are also NSAIDs) appears to prevent blood-vessel alterations associated with vision loss in diabetic patients, according to a report in Sept. Archives of Opthamology. J.G. Cunha-Vaz, MD/PhD, et al, of U.Illinois compared Suldinac treatment with placebo in a group of 24 Insulin-dependent diabetic patients and found that treated patients "had a significant beneficial effect on the breakdown of the blood-retinal barrier." They say that long term studies are now in order "to determine if the progression and development of diabetic retinopathy and final vision loss can be prevented." -- Craig Werner !philabs!aecom!werner "Why is it that half the calories is twice the price?"